Doctor of Medicine. Specialist in Internal Medicine. Cardiovascular Risk Consultation. Internal Medicine Service. Palencia University Welfare Complex

Vice-president of the Valencian Society of Geriatrics and Gerontology. She currently works in a Hospital at Home Unit.

His team investigates the role of activity-driven gene expression and chromatin modifications in neuronal plasticity, learning and memory.

The main objective of her researching group is to understand the mechanisms regulating stem cell homeostasis and regenerative functions.

Leader of the Uhlirova Lab, that studies stress resilience and ageing in Drosophila intestine.

PhD in Biology from Universidad de Barcelona. Postdoctoral research in Harvard University and Tufts University.

Telecommunications Engineer from the Polytechnics University of Valencia (UPV). He works in the field of radiological image processing and analysis.

PhD in industrial engineering from the Polytechnic University of Valencia. Working now at the Biomechanics Institute of Valencia.

Professor of Human Anatomy at the Faculty of Medicine of the University of Murcia. Director of the Official Aging Research Institute of Murcia.

Dr. Jay Sarkar is a Co-Founder for Turn Biotechnologies, a Stanford-born biotechnology company focused on multifaceted age-reversal via epigenetic reprogramming.

Doctor specialising in Family and Community Healthcare. PhD in Pharmacology from the University of Valencia.

Entraigues Abramson has been part of SRF since its founding days (2009) and before that, part of Methuselah Foundation (co-founded by Dave Gobel and Dr. Aubrey de Grey).

He is Professor of the Foundations of Economic Analysis at the UNED, where he was Director of the International PhD School and where he currently coordinates the Doctoral Programme in Economics and Business.

Chair of the Gerontopole & Department of Geriatric Internal Medicine at the Toulouse University Hospital and member of INSERM UMR 1027, as well as chair of the WHO Collaborating Center for Frailty, Clinical Research and Geriatric Training.

Researcher in the Chronobiology Group of the University of Murcia on a project to understand the mechanisms associated with the ageing of the circadian system of vertebrate models.

He leads a UAM and IdiPAZ research group named with the acronym FARMAVASM, dedicated to the study of the mechanisms that produce deterioration of the vascular function in pathological conditions.

He is a co-founder and CEO at Senolytic Therapeutics Inc., a pharmaceutical company that develops a novel class of medicines by targeting senescence cells. He is also supporting investments and strategic partnerships at Life Biosciences Inc. in Europe.

Manuel Serrano obtained his PhD in 1991, from the Universidad Autónoma de Madrid. From 1991 to 1996, Serrano worked in the team of David Beach in Cold Spring Harbor Laboratory, NY. During this period, Serrano made his most important discovery with the identification and characterization of the gene p16.

Manuel Collado holds a PhD in Biology from the Universidad Autónoma de Madrid. Having previously worked in London, New York and at the Spanish National Cancer Research Centre (CNIO) in Madrid, he is currently at the Health Research Institute of Santiago de Compostela (IDIS).

In 2003 she received a European PhD degree from the Department of Physiology of the Faculty of Medicine of the University of Valencia.

Mari Carmen Gómez Cabrera gained her doctorate from the Department of Physiology of the University of Valencia in 2004 and received a thesis award.

Born in 1953, José Viña is Professor of Physiology at the University of Valencia. He obtained his PhD at Valencia University in 1976 and has honoris causa doctorates from the University of Rennes (France) and the University of Buenos Aires (Argentina).

PhD in Biochemistry and Molecular Biology. Ramón y Cajal National Award for Research, European Molecular Biology Organization (EMBO) Gold Medal for best European researcher under the age of 40.

Graduated in Biomedical Sciences at the University of Navarra, Manuel Corpas has worked at the National Institute of Bioinformatics and the Sanger Institute of genome analysis.